SFXN4 and ovarian carcinoma: Using this assay, we first showed that Fe-S formation was significantly reduced following knockdown of SFXN4 in both HGSOC cells (COV362 and OVCAR3) and endometrioid (MDAH2774) ovarian cancer cells (Fig. 2A).